Evidence map›Paper›PMID 31744916›Full record

ArticlemBio2019

The Immune Protein Calprotectin Impacts Clostridioides difficile Metabolism through Zinc Limitation.

Christopher A Lopez, William N Beavers, Andy Weiss, Reece J Knippel, Joseph P Zackular, Walter Chazin, Eric P Skaar

Open access · goldAbstract read
In one paragraph

Article in mBio, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Review
  3. Microbial Biosensor for Sensing and Treatment of Intestinal Inflammation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  4. Article
  5. Article
  6. mSphere · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Characterizing metabolic drivers ofFrontiers in pharmacology · 2023
    Article
  13. Review
  14. Capturing the environment of the Clostridioides difficile infection cycle.Nature reviews. Gastroenterology & hepatology · 2022
    Review
  15. A unique class of ZnNature communications · 2022
    Article
  16. Article
  17. Review
  18. Microbial genomics · 2021
    Article
  19. Yersiniabactin contributes to overcoming zinc restriction duringProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Christopher A LopezDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
William N BeaversDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Andy WeissDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Reece J KnippelDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Joseph P ZackularDepartment of Pathology and Laboratory Medicine, Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Walter ChazinDepartment of Chemistry, Vanderbilt University, Nashville, Tennessee, USA.
Eric P SkaarDepartment of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA eric.skaar@vumc.org.
Vanderbilt University Medical Center · USUniversity of Pennsylvania · USVanderbilt University · US

Funding

Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Chemistry-Biology Interface Training GrantT32GM065086 · NIGMS · VANDERBILT UNIVERSITY · PI BACHMANN, BRIAN O, SULIKOWSKI, GARY ALLEN · 2002 to 2022
$7.0M
Childhood Infections Research ProgramT32AI095202 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI JAMES E CASSAT · 2011 to 2026
$4.2M
MOLECULAR PARASITOLOGY TRAINING PROGRAMT32AI007281 · NIAID · MEHARRY MEDICAL COLLEGE · PI NDE, PIUS N · 1985 to 2025
$3.2M
High-potency nitro antimicrobials for topical treatment of trichomoniasisR41AI118089 · NIAID · DESIGNMEDIX, INC. · PI ECKMANN, LARS, PEYTON, DAVID H · 2016 to 2016
$354k
The Impact of Vancomycin-Resistant Entercoccus on Clostridium difficile InfectionK22AI137220 · NIAID · CHILDREN'S HOSP OF PHILADELPHIA · PI ZACKULAR, JOSEPH PAUL · 2019 to 2020
$270k
The impact of dietary metals on the gut microbiome and Clostridium difficile infectionF32AI120553 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ZACKULAR, JOSEPH PAUL · 2015 to 2017
$109k
NIAID NIH HHS F32 AI120553NIAID NIH HHS K22 AI137220NIAID NIH HHS R41 AI118089NIAID NIH HHS T32 AI007281NIAID NIH HHS T32 AI095202NIDDK NIH HHS P30 DK058404NIGMS NIH HHS T32 GM065086
6 · The paper itself

Abstract

The intestines house a diverse microbiota that must compete for nutrients to survive, but the specific limiting nutrients that control pathogen colonization are not clearly defined.

Indexed as

Energy MetabolismClostridioides difficileClostridium InfectionsFermentationGene Expression Regulation, BacterialLeukocyte L1 Antigen ComplexProlineZincLeukocyte L1 Antigen ComplexProlineZinccalprotectinClostridioides difficileprolineStickland fermentationzinc

Identifiers

PMID31744916
PMCPMC6867894
OpenAlexW2987746896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.